Published in Postgrad Med J on September 01, 1997
Distal pancreatectomy: en-bloc splenectomy vs spleen-preserving pancreatectomy. HPB (Oxford) (2005) 0.98
Pancreatoduodenectomy in the treatment of chronic pancreatitis. World J Surg (2003) 0.95
Carcinoma of the head of the pancreas versus chronic pancreatitis: diagnostic dilemma with significant consequences. World J Surg (2003) 0.94
Clinical significance of tumor-associated antigen RCAS1 expression in human pancreatic ductal adenocarcinoma. Dig Dis Sci (2008) 0.90
Predictors of malignancy in chronic calcific pancreatitis with head mass. World J Gastrointest Surg (2013) 0.79
Head mass in chronic pancreatitis: Inflammatory or malignant. World J Gastrointest Endosc (2015) 0.76
Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med (1993) 7.67
ERCP. Gut (1977) 4.47
Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg (1995) 3.42
The clinical utility of the CA 19-9 tumor-associated antigen. Am J Gastroenterol (1990) 3.20
Microcystic adenomas of the pancreas (glycogen-rich cystadenomas): a clinicopathologic study of 34 cases. Am J Clin Pathol (1978) 2.81
Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg (1993) 2.26
Serous cystadenocarcinoma of the pancreas: a new entity? Am J Surg Pathol (1989) 2.03
Analysis of nerves in chronic pancreatitis. Gastroenterology (1988) 2.01
Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma. Ann Surg (1993) 1.97
Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology (1994) 1.68
Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg (1991) 1.65
Immunochemical characterization and quantitative distribution of pancreatic stone protein in sera and pancreatic secretions in pancreatic disorders. Gastroenterology (1990) 1.60
Exocrine pancreatic tumours and their histological classification. A study based on 167 autopsy and 97 surgical cases. Histopathology (1983) 1.54
Life-style risk factors for pancreatic cancer in Louisiana: a case-control study. Am J Epidemiol (1988) 1.54
Free radicals in medicine. II. Involvement in human disease. Mayo Clin Proc (1988) 1.49
Aetiology of pancreatic cancer. Br J Surg (1990) 1.49
Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer. Gastroenterology (1996) 1.43
Hyperplastic, preneoplastic and neoplastic lesions found in 83 human pancreases. Am J Clin Pathol (1982) 1.42
Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study. Br J Cancer (1985) 1.34
Microcystic adenomas (serous cystadenomas) of pancreas. A clinicopathologic investigation of eight cases with immunohistochemical and ultrastructural studies. Am J Surg Pathol (1986) 1.34
Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography. Gut (1995) 1.23
Pancreatitis in Finland between 1970 and 1989. Gut (1993) 1.22
Conservation of pancreatic tissue by combined gastric, biliary, and pancreatic duct drainage for pain from chronic pancreatitis. Am J Surg (1985) 1.16
Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. Ann Surg (1993) 1.12
Pancreolauryl and NBT-PABA tests. Are serum tests more practicable alternatives to urine tests in the diagnosis of exocrine pancreatic insufficiency? Gastroenterology (1986) 1.12
Epidemiology of pancreatic cancer. World J Surg (1984) 1.11
Carcinoma of the pancreas. J Pathol (1979) 1.09
Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US. Radiology (1995) 1.02
National statistics for diet, alcohol consumption, and chronic pancreatitis in England and Wales, 1960-88. Gut (1991) 1.02
MR imaging of the pancreas. Radiology (1993) 0.94
The duodenum preserving resection of the head of the pancreas (DPRHP) in patients with chronic pancreatitis and an inflammatory mass in the head. An alternative surgical technique to the Whipple operation. Acta Chir Scand (1990) 0.90
Pancreatic morphology and function in relationship to pain in chronic pancreatitis. Int J Pancreatol (1987) 0.87
Pathogenesis of chronic pancreatitis. Gut (1990) 0.85
Histological typing of pancreatic and periampullary carcinoma. Eur J Surg Oncol (1991) 0.82
Fine-needle aspiration biopsy of pancreatic ductal adenocarcinoma: loss of diagnostic accuracy with small tumors. J Surg Oncol (1994) 0.81
Selenium and acute alcoholism. Am J Clin Nutr (1983) 0.78
Current applicability of duplex Doppler ultrasonography in pancreatic head and biliary malignancies. Baillieres Clin Gastroenterol (1995) 0.76
Identification of genes required for cytoplasmic localization in early C. elegans embryos. Cell (1988) 4.98
Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg (1995) 3.42
Management of bile duct stones in the era of laparoscopic cholecystectomy. Br J Surg (1994) 2.91
The C. elegans par-4 gene encodes a putative serine-threonine kinase required for establishing embryonic asymmetry. Development (2000) 2.84
Successes, failures, early complications and their management following endoscopic sphincterotomy: results in 394 consecutive patients from a single centre. Br J Surg (1985) 2.66
Inflammatory mediators in acute pancreatitis. J Pathol (2000) 2.66
Colon perforation during colonoscopy: surgical versus conservative management. Br J Surg (1991) 2.58
Prospective randomised study of preoperative endoscopic sphincterotomy versus surgery alone for common bile duct stones. Br Med J (Clin Res Ed) (1987) 2.48
Calcium-dependent enzyme activation and vacuole formation in the apical granular region of pancreatic acinar cells. Proc Natl Acad Sci U S A (2000) 2.34
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer (2005) 2.32
Endoscopic sphincterotomy for common bile duct calculi in patients with gall bladder in situ considered unfit for surgery. Gut (1988) 2.22
Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer. Dig Surg (2005) 2.16
Early and late complications after pancreatic necrosectomy. Surgery (2005) 2.03
Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res (2000) 1.99
PALB2 mutations in European familial pancreatic cancer families. Clin Genet (2010) 1.99
Current standards of surgery for pancreatic cancer. Br J Surg (2004) 1.92
The management of common bile duct calculi by endoscopic sphincterotomy in patients with gallbladders in situ. Br J Surg (1984) 1.76
Contrast-enhanced abdominal computed tomography scanning and prediction of severity of acute pancreatitis: a prospective study. Br J Surg (1989) 1.75
Serial computed tomography scanning in acute pancreatitis: a prospective study. Gut (1989) 1.63
Evaluation of herniography in the diagnosis of an occult abdominal wall hernia in symptomatic adults. Br J Surg (1990) 1.60
Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy. Br J Cancer (2007) 1.58
Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res (1995) 1.57
Relation of diagnostic serum amylase levels to aetiology and severity of acute pancreatitis. Gut (1992) 1.53
Management of acute cholangitis and the impact of endoscopic sphincterotomy. Br J Surg (1986) 1.53
Chemical treatment of stones in the biliary tree. Br J Surg (1986) 1.53
The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut (2002) 1.50
Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses. Br J Cancer (2008) 1.50
Stapled versus sutured closure of loop ileostomy: a randomized controlled trial. Ann Surg (2000) 1.50
In vitro transcription of a silkworm 5S RNA gene requires an upstream signal. Proc Natl Acad Sci U S A (1984) 1.49
A prospective study of ERCP and endoscopic sphincterotomy in the diagnosis and treatment of gallstone acute pancreatitis. A rational and safe approach to management. Arch Surg (1986) 1.46
Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer. Br J Cancer (2011) 1.45
Research in higher surgical training--the West Midlands view. Ann R Coll Surg Engl (1993) 1.40
Molecular analysis of the APC gene in 205 families: extended genotype-phenotype correlations in FAP and evidence for the role of APC amino acid changes in colorectal cancer predisposition. J Med Genet (1999) 1.39
Complications of pancreatic cancer resection. Dig Surg (2002) 1.38
Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase. Neuroscience (2006) 1.37
Minimally invasive retroperitoneal pancreatic necrosectomy. Dig Surg (2003) 1.34
Complete pancreatic encasement of the proximal hepatic portal vein: a previously undescribed congenital anomaly. Br J Surg (1997) 1.33
Biology and management of pancreatic cancer. Postgrad Med J (2008) 1.32
A surgical and pathological based classification of resective treatment of pancreatic cancer. Summary of an international workshop on surgical procedures in pancreatic cancer. Dig Surg (1999) 1.32
Choledochoduodenostomy, transduodenal sphincteroplasty and sphincterotomy for calculi of the common bile duct. Surg Gynecol Obstet (1987) 1.29
Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma. J Pathol (1997) 1.29
K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma. Int J Cancer (2000) 1.27
Review article: chemotherapy for pancreatic cancer. Aliment Pharmacol Ther (2003) 1.25
The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer. Ann N Y Acad Sci (1999) 1.23
Acute pancreatitis as a model of sepsis. J Antimicrob Chemother (1998) 1.23
Endoscopic sphincterotomy for retained common bile duct stones in patients with T-tube in situ in the early postoperative period. Br J Surg (1986) 1.23
Preoperative CA19-9 levels and lymph node ratio are independent predictors of survival in patients with resected pancreatic ductal adenocarcinoma. Dig Surg (2008) 1.22
Frequency and impact of extracolonic findings detected at computed tomographic colonography in a symptomatic population. Br J Surg (2007) 1.22
Premature rupture of the fetal membranes. A review. Am J Obstet Gynecol (1970) 1.21
Expression of protein kinase C isoenzymes in colorectal cancer tissue and their differential activation by different bile acids. Int J Cancer (1995) 1.21
Randomized trial of oral sodium phosphate compared with oral sodium picosulphate (Picolax) for elective colorectal surgery and colonoscopy. Dig Surg (2000) 1.16
Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease. Br J Cancer (1996) 1.16
Detection of gall stones after acute pancreatitis. Gut (1985) 1.15
Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research Council. J Clin Oncol (1996) 1.14
Screening practice for familial adenomatous polyposis: the potential for regional registers. Br J Surg (1993) 1.14
Predictive diagnosis of familial adenomatous polyposis with linked DNA markers: population based study. BMJ (1992) 1.14
Preoperative resolution of jaundice following biliary stenting predicts more favourable early survival in resected pancreatic ductal adenocarcinoma. Ann Surg Oncol (2008) 1.14
Pancreatic hamartoma. Pancreatology (2004) 1.12
Resources and costs associated with incidental extracolonic findings from CT colonogaphy: a study in a symptomatic population. Br J Radiol (2006) 1.12
Maternal inheritance pattern of hereditary pancreatitis in patients with pancreatic carcinoma. J Natl Cancer Inst (1999) 1.11
Analysis of the Birt-Hogg-Dubé (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer. J Med Genet (2003) 1.10
Surgery in the treatment of acute pancreatitis--minimal access pancreatic necrosectomy. Scand J Surg (2005) 1.09
Lipid peroxidation and prostaglandins in colorectal cancer. Br J Surg (1994) 1.09
Genotype-phenotype correlation between position of constitutional APC gene mutation and CHRPE expression in familial adenomatous polyposis. Hum Genet (1994) 1.08
Inflammatory mediators as therapeutic targets in acute pancreatitis. Curr Opin Investig Drugs (2001) 1.08
A phase II trial of marimastat in advanced pancreatic cancer. Br J Cancer (2001) 1.08
Diagnosis, treatment and outcome of pancreatoblastoma. Pancreatology (2004) 1.07
The urgent diagnosis of gallstones in acute pancreatitis: a prospective study of three methods. Br J Surg (1984) 1.05
Risk of pancreatic ductal adenocarcinoma in chronic pancreatitis. Gut (2002) 1.05
Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo. Gene Ther (2001) 1.04
Technetium labelled red blood cell scintigraphy in the diagnosis of intestinal haemorrhage. Ann R Coll Surg Engl (1985) 1.04
Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis. Br J Cancer (1994) 1.02
Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility gene loci and in chromosomes 10p, 10q and 16q in human prostate cancer. Br J Urol (1994) 1.02
Duodenal gangliocytic paraganglioma presenting as an ampullary tumor. Int J Pancreatol (1996) 1.02
Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis. Br J Surg (2002) 1.02
Surgery for midgut carcinoid. Endocr Relat Cancer (2003) 1.02
Tuberculosis of the pancreas presenting as metastatic pancreatic carcinoma. A case report and review of the literature. Dig Surg (2000) 1.01
S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility. Br J Cancer (2009) 1.01
New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel. Ann Oncol (2011) 1.00
Peutz-Jeghers syndrome and screening for pancreatic cancer. Br J Surg (2006) 1.00
The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas. Br J Cancer (2006) 1.00
Pancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol (2008) 1.00
Anticipation in familial pancreatic cancer. Gut (2005) 1.00
iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance. Br J Cancer (2013) 0.99
Reduction of mucosal crypt cell proliferation in patients with colorectal adenomatous polyps by dietary calcium supplementation. Br J Surg (1992) 0.99
Carbohydrate antigen 19.9 accurately selects patients for laparoscopic assessment to determine resectability of pancreatic malignancy. Br J Surg (2008) 0.99
Reorganisation of Wnt-response pathways in colorectal tumorigenesis. Br J Cancer (2008) 0.98
Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer. Br J Cancer (2010) 0.98
Oestrogen and progesterone receptors in colorectal cancer and human colonic cancer cell lines. Br J Surg (1993) 0.98
Faecal unconjugated bile acids in patients with colorectal cancer or polyps. Gut (1992) 0.97
Audit of topical glyceryl trinitrate for treatment of fissure-in-ano. Ann R Coll Surg Engl (2000) 0.97
Adjuvant therapy in pancreatic cancer. World J Gastroenterol (2001) 0.97
Localization of lower gastrointestinal bleeding using in vivo technetium-99m-labelled red blood cell scintigraphy. Br J Surg (1989) 0.97
Needle aspiration in the treatment of pancreatic pseudocyst in childhood. Ann R Coll Surg Engl (1983) 0.97